27d agoThe FlyBEARISH 38Earnings
Archived explainer. For the current picture see today's CLBT page.
Why Is CELLEBRITE DI LTD A (CLBT) Stock Down Today?
By the Top Tier Newswire AI Desk · August 17, 2026 at 10:15 AM ET · reviewed against 9 wire stories
CELLEBRITE DI LTD A (CLBT) is down -6.55% in the latest session. Our newswire has captured 9 stories on CLBT across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 37/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Cellebrite DI Ltd A (CLBT) fell 6.55% to $10.41 in the session, marking a continuation of a downward trend that has seen the stock drop 29.3% over the last eight trading days. The decline came amid a series of downgraded price targets and revenue forecasts from key analysts, which raised concerns about the company’s ability to meet expectations. The stock opened with a 1.3% gap down and traded to a session low of $10.40 before closing near that level.
What Happened
Cellebrite cut its full-year 2026 revenue guidance to a range of $555 million to $561 million, down from the previous $565 million to $571 million. The company also projected third-quarter revenue between $145 million and $148 million, below the consensus estimate of $150.3 million. While the Q2 adjusted earnings per share of 11 cents matched expectations, the downward revisions to both full-year and quarterly revenue signaled a slowdown in growth. In response, multiple analysts reduced their price targets: TD Cowen cut its target to $15 from $23, JPMorgan lowered it to $16 from $20, and Deutsche Bank and Lake Street also reduced their targets. Executive selling, including sales by the CEO and CMO, added to the bearish sentiment.
What The Data Shows
The stock opened at $11.00 and traded as high as $11.42 before falling sharply to a session low of $10.40. Volume reached 1.2 million shares, which is 0.6 times the 3-month daily average. The stock has traded within a 52-week range of $9.58 to $19.98, and the recent decline has pushed it closer to the lower end of that range. Over the last 90 days, insiders have sold a total of $4.5 million worth of shares, with no insider purchases reported. The 52-week tape also showed 19 fresh 52-week lows on August 17, indicating ongoing pressure.
What To Watch
The stock is now trading near key support levels. Coverage breadth remains broad, with nine stories published in 36 hours, and further price target adjustments or earnings updates could influence the next move.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CLBT by the numbers
Last: $10.41Session: -6.55%7 sessions: -32.47%Coverage: 9 stories / 1 sourcesAI sentiment: 37/100 (bearish)Mkt cap: $3.9BP/E: 45.052w: $9.58 to $19.98
The headlines behind the move
27d agoThe FlyBEARISH 42Earnings
Cellebrite sees Q3 revenue $145M-$148M, consensus $150.3M
27d agoThe FlyNEUTRAL 50Earnings
Cellebrite reports Q2 adjusted EPS 11c, consensus 11c
27d agoThe FlyBEARISH 32General
Cellebrite falls -31.8%
27d agoThe FlyBEARISH 34Analyst
Cellebrite price target lowered to $15 from $23 at TD Cowen
27d agoThe FlyBEARISH 34Analyst
Cellebrite price target lowered to $16 from $20 at JPMorgan
27d agoThe FlyBEARISH 34Analyst
Cellebrite price target lowered to $14 from $20 at Deutsche Bank
27d agoThe FlyBEARISH 38Analyst
Cellebrite price target lowered to $15 from $21 at Lake Street
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on CLBT: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CLBT move explainers: 2026-08-24 · 2026-08-18 · 2026-08-17 · 2026-08-13